BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fischer R, Cariers A, Reinehr R, Häussinger D. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology. 2002;123:845-861. [PMID: 12198711 DOI: 10.1053/gast.2002.35384] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Dec K, Łukomska A, Baranowska-Bosiacka I, Pilutin A, Maciejewska D, Skonieczna-Żydecka K, Derkacz R, Goschorska M, Wąsik A, Rębacz-Maron E, Gutowska I. Pre-and postnatal exposition to fluorides induce changes in rats liver morphology by impairment of antioxidant defense mechanisms and COX induction. Chemosphere 2018;211:112-9. [PMID: 30071422 DOI: 10.1016/j.chemosphere.2018.07.145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Ahmad A, Ahmad R. Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches. Saudi J Gastroenterol. 2012;18:155-167. [PMID: 22626794 DOI: 10.4103/1319-3767.96445]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Sommerfeld A, Reinehr R, Häussinger D. Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. J Biol Chem. 2009;284:22173-22183. [PMID: 19553664 DOI: 10.1074/jbc.M109.005355] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
4 Zandieh A, Payabvash S, Pasalar P, Morteza A, Zandieh B, Tavangar SM, Dehpour AR. Gadolinium chloride, a Kupffer cell inhibitor, attenuates hepatic injury in a rat model of chronic cholestasis. Hum Exp Toxicol 2011;30:1804-10. [PMID: 21339256 DOI: 10.1177/0960327111400106] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
5 Reinehr R, Becker S, Eberle A, Grether-beck S, Häussinger D. Involvement of NADPH Oxidase Isoforms and Src Family Kinases in CD95-dependent Hepatocyte Apoptosis. Journal of Biological Chemistry 2005;280:27179-94. [DOI: 10.1074/jbc.m414361200] [Cited by in Crossref: 182] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
6 Filer A, Pitzalis C, Buckley CD. Targeting the stromal microenvironment in chronic inflammation. Curr Opin Pharmacol 2006;6:393-400. [PMID: 16682252 DOI: 10.1016/j.coph.2006.03.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
7 Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 2003;38:1188-1198. [PMID: 14578857 DOI: 10.1053/jhep.2003.50472] [Cited by in Crossref: 323] [Cited by in F6Publishing: 296] [Article Influence: 17.9] [Reference Citation Analysis]
8 Siegmund SV, Seki E, Osawa Y, Uchinami H, Cravatt BF, Schwabe RF. Fatty Acid Amide Hydrolase Determines Anandamide-induced Cell Death in the Liver. Journal of Biological Chemistry 2006;281:10431-8. [DOI: 10.1074/jbc.m509706200] [Cited by in Crossref: 76] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
9 Almeda-Valdes P, Aguilar Olivos NE, Barranco-Fragoso B, Uribe M, Méndez-Sánchez N. The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Biomed Res Int. 2015;2015:768071. [PMID: 26339640 DOI: 10.1155/2015/768071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
10 Friedman SL. Hepatic fibrosis-overview. Toxicology. 2008;254:120-129. [PMID: 18662740 DOI: 10.1016/j.tox.2008.06.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 227] [Article Influence: 18.5] [Reference Citation Analysis]
11 Senoo H, Mezaki Y, Fujiwara M. The stellate cell system (vitamin A-storing cell system). Anat Sci Int. 2017;92:387-455. [PMID: 28299597 DOI: 10.1007/s12565-017-0395-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
12 Cursio R, Gugenheim J. Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation. J Transplant 2012;2012:164329. [PMID: 22530107 DOI: 10.1155/2012/164329] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
13 Xu R, Zhang Z, Wang FS. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol 2012;9:296-301. [PMID: 22157623 DOI: 10.1038/cmi.2011.53] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 8.4] [Reference Citation Analysis]
14 Elpek G&. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014; 20(23): 7260-7276 [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 154] [Article Influence: 24.7] [Reference Citation Analysis]
15 Ma P, Gao C, Yi J, Zhao J, Liang S, Zhao Y, Ye Y, Bai J, Zheng Q, Dou K, Han H, Qin H. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. Journal of Hepatology 2017;67:770-9. [DOI: 10.1016/j.jhep.2017.05.022] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 16.3] [Reference Citation Analysis]
16 Tang X, Yang J, Li J. Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis. Life Sciences 2009;84:552-7. [DOI: 10.1016/j.lfs.2009.01.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
17 Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011;35:787-793. [PMID: 21284667 DOI: 10.1111/j.1530-0277.2010.01399.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 112] [Article Influence: 10.4] [Reference Citation Analysis]
18 Giannandrea M, Pierce RH, Crispe IN. Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice. Hepatology 2009;49:2010-20. [PMID: 19291774 DOI: 10.1002/hep.22869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
19 邵祥强, 肖华胜. 肝纤维化发病机制与临床诊断的研究进展. 世界华人消化杂志 2011; 19(3): 268-274 [DOI: 10.11569/wcjd.v19.i3.268] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
20 Martinez-palacian A, Kanse SM, Weiskirchen R. Factor VII activating protease (FSAP): A novel protective factor in liver fibrosis. Prot Clin Appl 2014;8:438-46. [DOI: 10.1002/prca.201300078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
21 Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond). 2007;112:265-280. [PMID: 17261089 DOI: 10.1042/cs20060242] [Cited by in Crossref: 183] [Cited by in F6Publishing: 88] [Article Influence: 13.1] [Reference Citation Analysis]
22 Kong D, Zhang F, Zhang Z, Lu Y, Zheng S. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential. Biomed Pharmacother. 2013;67:246-250. [PMID: 23201010 DOI: 10.1016/j.biopha.2012.10.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
23 Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci 2014;15:9184-208. [PMID: 24865485 DOI: 10.3390/ijms15069184] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
24 Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-jun N terminal kinase activation independent from the interferon pathway. Hepatology 2013;57:23-36. [DOI: 10.1002/hep.25966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
25 Husain H, Ahmad R, Khan A, Inamuddin, Asiri AM. Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis. International Journal of Biological Macromolecules 2018;111:379-92. [DOI: 10.1016/j.ijbiomac.2017.12.168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Friedman SL. Mac the knife? Macrophages– the double-edged sword of hepatic fibrosis. J Clin Invest 2005;115:29-32. [DOI: 10.1172/jci200523928] [Cited by in Crossref: 64] [Article Influence: 4.0] [Reference Citation Analysis]
27 Ahmad A, Ahmad R. Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches. Saudi J Gastroenterol 2012;18:155-67. [PMID: 22626794 DOI: 10.4103/1319-3767.96445] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
28 Cai SM, Yang RQ, Li Y, Ning ZW, Zhang LL, Zhou GS, Luo W, Li DH, Chen Y, Pan MX, Li X. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation. Antioxid Redox Signal 2016;24:795-812. [PMID: 26728324 DOI: 10.1089/ars.2015.6498] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 8.4] [Reference Citation Analysis]
29 Ritz T, Krenkel O, Tacke F. Dynamic plasticity of macrophage functions in diseased liver. Cell Immunol 2018;330:175-82. [PMID: 29454647 DOI: 10.1016/j.cellimm.2017.12.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
30 Pellicoro A, Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Fibrogenesis Tissue Repair. 2012;5:S26. [PMID: 23259590 DOI: 10.1186/1755-1536-5-s1-s26] [Cited by in Crossref: 63] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
31 El Taghdouini A, van Grunsven LA. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis. Expert Rev Gastroenterol Hepatol 2016;10:1397-408. [PMID: 27762150 DOI: 10.1080/17474124.2016.1251309] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
32 Friedman SL. Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis. J Clin Invest. 2005;115:29-32. [PMID: 15630440 DOI: 10.1172/jci23928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 36] [Article Influence: 0.1] [Reference Citation Analysis]
33 Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-82. [PMID: 16423888 DOI: 10.1136/gut.2005.082701] [Cited by in Crossref: 116] [Cited by in F6Publishing: 114] [Article Influence: 7.7] [Reference Citation Analysis]
34 Duval F, Moreno-Cuevas JE, González-Garza MT, Maldonado-Bernal C, Cruz-Vega DE. Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. Int J Inflam 2015;2015:943497. [PMID: 25954568 DOI: 10.1155/2015/943497] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
35 Ahsan MK, Mehal WZ. Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. Front Pharmacol. 2014;5:69. [PMID: 24782773 DOI: 10.3389/fphar.2014.00069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
36 Reinehr R, Sommerfeld A, Häussinger D. CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells. Gastroenterology 2008;134:1494-506. [PMID: 18471522 DOI: 10.1053/j.gastro.2008.02.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
37 Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003] [Cited by in Crossref: 1758] [Cited by in F6Publishing: 1748] [Article Influence: 135.2] [Reference Citation Analysis]
38 Pritchard MT, McCracken JM. Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar? Curr Drug Targets 2015;16:1332-46. [PMID: 26302807 DOI: 10.2174/1389450116666150825111439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
39 Stalnikowitz DK, Weissbrod AB. Liver fibrosis and inflammation. A review. Annals of Hepatology 2003;2:159-63. [DOI: 10.1016/s1665-2681(19)32127-1] [Cited by in Crossref: 98] [Article Influence: 5.4] [Reference Citation Analysis]
40 Collins BH, Holzknecht ZE, Lynn KA, Sempowski GD, Smith CC, Liu S, Parker W, Rockey DC. Association of age-dependent liver injury and fibrosis with immune cell populations. Liver Int. 2013;33:1175-1186. [PMID: 23710620 DOI: 10.1111/liv.12202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
41 Senoo H, Yoshikawa K, Morii M, Miura M, Imai K, Mezaki Y. Hepatic stellate cell (vitamin A-storing cell) and its relative--past, present and future. Cell Biol Int. 2010;34:1247-1272. [PMID: 21067523 DOI: 10.1042/cbi20100321] [Cited by in Crossref: 109] [Cited by in F6Publishing: 41] [Article Influence: 10.9] [Reference Citation Analysis]
42 Puche JE, Saiman Y, Friedman SL. Hepatic stellate cells and liver fibrosis. Compr Physiol. 2013;3:1473-1492. [PMID: 24265236 DOI: 10.1002/cphy.c120035] [Cited by in Crossref: 347] [Cited by in F6Publishing: 343] [Article Influence: 49.6] [Reference Citation Analysis]
43 Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology. 2004;231:482-490. [PMID: 15128993 DOI: 10.1148/radiol.2312030160] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
44 Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CP, Andraus W, Alves VA, Leclercq I. Experimental models of liver fibrosis. Arch Toxicol. 2016;90:1025-1048. [PMID: 26047667 DOI: 10.1007/s00204-015-1543-4] [Cited by in Crossref: 108] [Cited by in F6Publishing: 106] [Article Influence: 18.0] [Reference Citation Analysis]
45 Marcos R. Depletion of hepatic stellate cells: have Kupffer cells lost their bad neighbor? J Hepatol 2014;61:714-5. [PMID: 24893125 DOI: 10.1016/j.jhep.2014.05.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Taimr P. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37:87-95. [DOI: 10.1053/jhep.2003.50002] [Cited by in Crossref: 155] [Cited by in F6Publishing: 155] [Article Influence: 8.6] [Reference Citation Analysis]
47 Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol. 2009;8:283-291. [PMID: 20009126 DOI: 10.1016/s1665-2681(19)31740-5] [Cited by in Crossref: 69] [Cited by in F6Publishing: 1] [Article Influence: 6.3] [Reference Citation Analysis]
48 Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 2013;305:C789-99. [PMID: 23903700 DOI: 10.1152/ajpcell.00230.2013] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 18.0] [Reference Citation Analysis]
49 Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg WM. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. World J Gastroenterol 2020; 26(2): 109-133 [PMID: 31969775 DOI: 10.3748/wjg.v26.i2.109] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
50 Campana L, Iredale JP. Extracellular Matrix Metabolism and Fibrotic Disease. Curr Pathobiol Rep 2014;2:217-24. [DOI: 10.1007/s40139-014-0058-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
51 Fan JH, Feng GG, Huang L, Tang GD, Jiang HX, Xu J. Naofen promotes TNF-α-mediated apoptosis of hepatocytes by activating caspase-3 in lipopolysaccharide-treated rats. World J Gastroenterol 2014; 20(17): 4963-4971 [PMID: 24803807 DOI: 10.3748/wjg.v20.i17.4963] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
52 Basu A, Saito K, Meyer K, Ray RB, Friedman SL, Chang YH, Ray R. Stellate cell apoptosis by a soluble mediator from immortalized human hepatocytes. Apoptosis. 2006;11:1391-1400. [PMID: 16830231 DOI: 10.1007/s10495-006-8312-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
53 Wang J, Zhou X, Cui L, Yan L, Liang J, Cheng X, Qiao L, Shi Y, Han Z, Cao Y. The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. Cytotherapy. 2010;12:1022-1034. [PMID: 20849360 DOI: 10.3109/14653249.2010.515578] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
54 Fischer R, Reinehr R, Lu TP, Schönicke A, Warskulat U, Dienes HP, Häussinger D. Intercellular communication via gap junctions in activated rat hepatic stellate cells. Gastroenterology 2005;128:433-48. [PMID: 15685554 DOI: 10.1053/j.gastro.2004.11.065] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
55 Chang J, Hisamatsu T, Shimamura K, Yoneno K, Adachi M, Naruse H, Igarashi T, Higuchi H, Matsuoka K, Kitazume MT. Activated hepatic stellate cells mediate the differentiation of macrophages. Hepatol Res. 2013;43:658-669. [PMID: 23107150 DOI: 10.1111/j.1872-034x.2012.01111.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
56 Bandapalli OR, Geheeb M, Kobelt D, Kuehnle K, Elezkurtaj S, Herrmann J, Gressner AM, Weiskirchen R, Beule D, Blüthgen N, Herzel H, Franke C, Brand K. Global analysis of host tissue gene expression in the invasive front of colorectal liver metastases. Int J Cancer 2006;118:74-89. [PMID: 16080196 DOI: 10.1002/ijc.21307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
57 Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology. 2006;130:435-452. [PMID: 16472598 DOI: 10.1053/j.gastro.2005.10.055] [Cited by in Crossref: 374] [Cited by in F6Publishing: 347] [Article Influence: 24.9] [Reference Citation Analysis]
58 Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009;86:513-28. [PMID: 19542050 DOI: 10.1189/JLB.0309135] [Cited by in Crossref: 242] [Cited by in F6Publishing: 157] [Article Influence: 20.2] [Reference Citation Analysis]
59 Lan L, Gorke S, Rau SJ, Zeisel MB, Hildt E, Himmelsbach K, Carvajal-Yepes M, Huber R, Wakita T, Schmitt-Graeff A, Royer C, Blum HE, Fischer R, Baumert TF. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J Immunol 2008;181:4926-35. [PMID: 18802096 DOI: 10.4049/jimmunol.181.7.4926] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
60 Higuchi H, Gores GJ. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. Am J Physiol Gastrointest Liver Physiol 2003;284:G734-8. [PMID: 12684208 DOI: 10.1152/ajpgi.00491.2002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 4.8] [Reference Citation Analysis]
61 Ramachandran P, Henderson NC. Antifibrotics in chronic liver disease: tractable targets and translational challenges. The Lancet Gastroenterology & Hepatology 2016;1:328-40. [DOI: 10.1016/s2468-1253(16)30110-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
62 Zakaria S, El-Sisi A. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2. J Immunotoxicol. 2016;13:453-462. [PMID: 26849241 DOI: 10.3109/1547691x.2015.1128022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
63 Sun YY, Li XF, Meng XM, Huang C, Zhang L, Li J. Macrophage Phenotype in Liver Injury and Repair. Scand J Immunol. 2017;85:166-174. [PMID: 27491503 DOI: 10.1111/sji.12468] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 10.5] [Reference Citation Analysis]
64 Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927-939. [PMID: 16151628 DOI: 10.1007/s10495-005-1055-4] [Cited by in Crossref: 294] [Cited by in F6Publishing: 287] [Article Influence: 19.6] [Reference Citation Analysis]
65 Gao B. Natural killer group 2 member D, its ligands, and liver disease: good or bad? Hepatology 2010;51:8-11. [PMID: 20034045 DOI: 10.1002/hep.23320] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
66 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
67 Fischer R, Baumert T, Blum HE. Hepatitis C virus infection and apoptosis. World J Gastroenterol 2007; 13(36): 4865-4872 [PMID: 17828818 DOI: 10.3748/wjg.v13.i36.4865] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 85] [Article Influence: 6.5] [Reference Citation Analysis]
68 Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007;363:247-252. [PMID: 17869217 DOI: 10.1016/j.bbrc.2007.05.150] [Cited by in Crossref: 168] [Cited by in F6Publishing: 172] [Article Influence: 12.0] [Reference Citation Analysis]
69 Lotersztajn S, Mallat A. Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 175-84. [DOI: 10.1016/b978-0-12-800134-9.00011-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1682] [Cited by in F6Publishing: 1626] [Article Influence: 129.4] [Reference Citation Analysis]